Clinical trial
Entolimod, an Adjuvant for Vaccine Augmentation
NCT03063736 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Entolimod, an Adjuvant for Vaccine Augmentation
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 8, 2017
- Completion date
- December 31, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
substance use disorders